An open label comparative clinical trial to evaluate The efiicacy of Udumbara Phala Churna and Lodhra - Shunthi Churna in the management of Asrigdara w.s.r. Heavy Menstrual Bleeding
Phase 2
- Conditions
- Health Condition 1: N920- Excessive and frequent menstruation with regular cycle
- Registration Number
- CTRI/2024/03/064711
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Subjects having confirm diagnosis of Asrigdara w.s.r. Abnormal Uterine Bleeding (AUB O&E)
Abnormal Uterine bleeding due to Ovulatory disorders and Endometrial disorders (without Pelvic Pathology)
Patients of age group between 20 to 40 years who are willing to take part in the study or those who have informed written consent. (Married and Unmarried)
Exclusion Criteria
patients below the age of 20 yrs and above the age of 40 yrs
All male candidates are excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decrease in Amount of Blood Flow <br/ ><br>Decrease in Duration of Blood FlowTimepoint: At Baseline and 90th Day
- Secondary Outcome Measures
Name Time Method Reduction in Pain <br/ ><br>Alteration in Hb% by 1%Timepoint: at Baseline and 90th day <br/ ><br>